A single 60-minute session of active transcutaneous auricular vagus nerve stimulation significantly increased resting-state frontal delta power compared to sham stimulation in healthy adults.
RCT (n=44)
Double-blind
1:1 allocation ratio
No
Does a single session of active transcutaneous auricular vagus nerve stimulation (taVNS) modulate resting-state brain oscillations in healthy subjects?
A single session of active taVNS increases resting-state low-frequency (delta) oscillatory activity mainly over the right frontal hemisphere in healthy subjects, suggesting activation of the fronto-vagal network.
Effect estimate: β 0.085 (95% CI 0.011-0.159)
Absolute Event Rate: 28.8% vs 27.4%
p-value: p=0.025
Transcutaneous auricular vagus nerve stimulation (taVNS) is a promising technique that potentially influences cortical activity, mainly increasing electroencephalography (EEG) power spectrum activity in low-frequency oscillations, and demonstrates potential therapeutic benefits for various pathologic conditions, like depression and chronic pain. To learn further about taVNS brain mechanisms, the present study investigated how using a single taVNS session can affect brain oscillations in healthy subjects. 44 healthy participants were included in this randomized, double-blind, sham-controlled trial. Participants were divided into the active and sham taVNS groups. Resting-state EEG power was analyzed across the frontal, central, and parietal regions in both hemispheres. Our findings demonstrated that active taVNS modulates low-frequency oscillations in the frontal areas of healthy subjects. After the intervention, the average delta power at the frontal region increased in the active group compared to the sham group. These changes were also observed with an increase in delta asymmetry (towards the right hemisphere) in the active group compared to the sham group. In healthy subjects, active taVNS selectively induces changes in the resting-state frontal brain oscillations. Our results suggest that taVNS increases homeostatic low-frequency oscillatory activity mainly over the right frontal hemisphere. Active taVNS induces activation of the fronto-vagal network, which has a therapeutic potential to generate salutogenic and balanced brain activity.
Camargo et al. (Fri,) conducted a rct in Healthy subjects (n=44). Transcutaneous auricular vagus nerve stimulation (taVNS) vs. Sham taVNS was evaluated on Change in resting-state frontal delta power (β 0.085, 95% CI 0.011-0.159, p=0.025). A single 60-minute session of active transcutaneous auricular vagus nerve stimulation significantly increased resting-state frontal delta power compared to sham stimulation in healthy adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: